Study of Bleeding With Extended Administration of an Oral Contraceptive

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Warner Chilcott
• Treatments: Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Norethindrone; Norethindrone Acetate; Polyestradiol phosphate

Criteria

Inclusion Criteria:

• Healthy women

• Age 25-40

• History of regular cycles

Exclusion Criteria:

• Current or recent (within 2 months) users of hormonal contraceptives

• Contraindications for use of hormonal contraception

• Conditions which affect the absorption or metabolism of steroid hormones

• BMI > 35